
Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation
Launched in 2016, PRIME provides targeted scientific and regulatory support to medications designed to address conditions with an unmet medical need; there are currently no licensed vaccines or treatments for Nipah virus. The additional support offered by …